The influence of statin characteristics on their safety and tolerability
Author:
Publisher
Hindawi Limited
Subject
General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1368-5031.2004.00355.x/fullpdf
Reference92 articles.
1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group.;Lancet,1994
2. Managing dyslipidemia in the high-risk patient;Stein;Am J Cardiol,2002
3. The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk;Corsini;Cardiovasc Drugs Ther,2003
4. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. A randomized controlled trial;Serruys;JAMA,2002
5. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial;Heart Protection Study Collaborative Group.;Lancet,2002
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy;Clinical Biochemistry;2024-02
2. Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions;Frontiers in Pharmacology;2023-02-09
3. RETRACTED ARTICLE: Simvastatin-loaded nano-niosomes efficiently downregulates the MAPK-NF-κB pathway during the acute phase of myocardial ischemia-reperfusion injury;Molecular Biology Reports;2022-09-12
4. Simvastatin in ternary solid dispersion formulations: Improved In vitro dissolution and anti-hyperlipidemia efficiency;Journal of Drug Delivery Science and Technology;2022-08
5. Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis;Cell Reports;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3